Psychological resilience and health‐related quality of life in 418 swedish women with primary breast cancer : Results from a prospective longitudinal study
(2021) In Cancers 13(9).- Abstract
Psychological resilience is considered a major protective psychological mechanism that enables a person to successfully handle significant adversities, e.g., a cancer diagnosis. Higher levels of resilience have been associated with higher levels of health‐related quality of life (HRQoL) in breast cancer (BC) patients, but research examining the longitudinal process of resilience is limited. The aim of this population‐based longitudinal study was to investigate resilience and HRQoL from diagnosis to one year later in 418 Swedish women with primary BC. Resilience was measured with the Connor–Davidson Resilience Scale 25, and HRQoL was measured with the Short Form Health Survey. The participants responded to questions regarding demographic... (More)
Psychological resilience is considered a major protective psychological mechanism that enables a person to successfully handle significant adversities, e.g., a cancer diagnosis. Higher levels of resilience have been associated with higher levels of health‐related quality of life (HRQoL) in breast cancer (BC) patients, but research examining the longitudinal process of resilience is limited. The aim of this population‐based longitudinal study was to investigate resilience and HRQoL from diagnosis to one year later in 418 Swedish women with primary BC. Resilience was measured with the Connor–Davidson Resilience Scale 25, and HRQoL was measured with the Short Form Health Survey. The participants responded to questions regarding demographic and study‐specific varia-bles. Clinicopathological variables were collected from the Swedish National Quality Register for Breast Cancer. The mean score for resilience was 70.6 (standard deviation, SD = 13.0) at diagnosis and 68.9 (SD = 14.0) one year later, p < 0.001. The level of trust in the treatment and financial situation demonstrated the greatest association with the change in resilience levels. No oncological treatment modality was associated with a change in resilience levels. HRQoL decreased over time in the co-hort. Resilience was positively associated with HRQoL at one year post diagnosis, which demon-strates that resilience is an important factor in maintaining HRQoL.
(Less)
- author
- Mohlin, Åsa LU ; Bendahl, Pär Ola LU ; Hegardt, Cecilia LU ; Richter, Corinna LU ; Hallberg, Ingalill Rahm LU and Rydén, Lisa LU
- organization
- publishing date
- 2021-05-01
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Breast cancer, Connor–Davidson Resilience Scale 25 (CD‐RISC25), Health‐related quality of life, Psychological resilience, Short Form Health Survey (SF‐36)
- in
- Cancers
- volume
- 13
- issue
- 9
- article number
- 2233
- publisher
- MDPI AG
- external identifiers
-
- pmid:34066499
- scopus:85105185881
- ISSN
- 2072-6694
- DOI
- 10.3390/cancers13092233
- language
- English
- LU publication?
- yes
- id
- 2f86c033-925b-45ac-b6ad-1e1c03da27d9
- date added to LUP
- 2021-05-31 10:55:37
- date last changed
- 2024-09-21 20:48:06
@article{2f86c033-925b-45ac-b6ad-1e1c03da27d9, abstract = {{<p>Psychological resilience is considered a major protective psychological mechanism that enables a person to successfully handle significant adversities, e.g., a cancer diagnosis. Higher levels of resilience have been associated with higher levels of health‐related quality of life (HRQoL) in breast cancer (BC) patients, but research examining the longitudinal process of resilience is limited. The aim of this population‐based longitudinal study was to investigate resilience and HRQoL from diagnosis to one year later in 418 Swedish women with primary BC. Resilience was measured with the Connor–Davidson Resilience Scale 25, and HRQoL was measured with the Short Form Health Survey. The participants responded to questions regarding demographic and study‐specific varia-bles. Clinicopathological variables were collected from the Swedish National Quality Register for Breast Cancer. The mean score for resilience was 70.6 (standard deviation, SD = 13.0) at diagnosis and 68.9 (SD = 14.0) one year later, p < 0.001. The level of trust in the treatment and financial situation demonstrated the greatest association with the change in resilience levels. No oncological treatment modality was associated with a change in resilience levels. HRQoL decreased over time in the co-hort. Resilience was positively associated with HRQoL at one year post diagnosis, which demon-strates that resilience is an important factor in maintaining HRQoL.</p>}}, author = {{Mohlin, Åsa and Bendahl, Pär Ola and Hegardt, Cecilia and Richter, Corinna and Hallberg, Ingalill Rahm and Rydén, Lisa}}, issn = {{2072-6694}}, keywords = {{Breast cancer; Connor–Davidson Resilience Scale 25 (CD‐RISC25); Health‐related quality of life; Psychological resilience; Short Form Health Survey (SF‐36)}}, language = {{eng}}, month = {{05}}, number = {{9}}, publisher = {{MDPI AG}}, series = {{Cancers}}, title = {{Psychological resilience and health‐related quality of life in 418 swedish women with primary breast cancer : Results from a prospective longitudinal study}}, url = {{http://dx.doi.org/10.3390/cancers13092233}}, doi = {{10.3390/cancers13092233}}, volume = {{13}}, year = {{2021}}, }